Bristol-Myers Squibb Company Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 332 trades in Bristol-Myers Squibb Company (NYSE: BMY) since 2012, across 56 members, worth an estimated $6.9M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 159 buys against 172 sells, a modestly sell-led skew, with Democratic members responsible for 47% of the trades and Republican members 53%. The most recent disclosure shown was filed July 2026, and Rohit Khanna has filed the most BMY transactions among those shown, with 7. Other recent filers include Mike Kelly, Alan Armstrong, and Gilbert Cisneros. One notable disclosed move was a purchase by Rohit Khanna on November 3, 2025, up 50.9% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Bristol-Myers Squibb Company's current Quantellect Tide Score is 72 out of 100 (High Tide), Top 15% of universe (3876); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Bristol-Myers Squibb Company (BMY) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Bristol-Myers Squibb congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
 Rohit Khanna House | Jul 6, 2026 | Jun 16, 2026 | 20 days | SELL |  $1,001 - $15,000 | +21.46% | Spouse | |
Rohit Khanna House | Jun 9, 2026 | May 15, 2026 | 25 days | BUY | $1,001 - $15,000 | +19.16% | Spouse | |
 Mike Kelly House | Jun 11, 2026 | May 7, 2026 | 35 days | SELL | $15,001 - $50,000 | +20.75% | Spouse | |
Rohit Khanna House | May 11, 2026 | Apr 13, 2026 | 28 days | BUY | $1,001 - $15,000 | +16.98% | Spouse | |
 Alan Armstrong Senate | Jul 21, 2026 | Mar 27, 2026 | 116 days | BUY | $1,001 - $15,000 | +17.22% | Self | |
Rohit Khanna House | Mar 9, 2026 | Feb 5, 2026 | 32 days | BUY | $1,001 - $15,000 | +15.29% | Spouse | |
Rohit Khanna House | Feb 6, 2026 | Jan 29, 2026 | 8 days | SELL | $15,001 - $50,000 | +26.42% | Spouse | |
Rohit Khanna House | Feb 6, 2026 | Jan 23, 2026 | 14 days | BUY | $1,001 - $15,000 | +25.56% | Child | |
 Gilbert Cisneros House | Jan 12, 2026 | Dec 19, 2025 | 24 days | BUY | $1,001 - $15,000 | +28.13% | Self | |
 Julie Johnson House | Jan 15, 2026 | Dec 18, 2025 | 28 days | SELL | $1,001 - $15,000 | +30.19% | Joint |
Bristol-Myers Squibb (BMY) congressional trading FAQ
Can members of Congress legally trade Bristol-Myers Squibb (BMY) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Bristol-Myers Squibb (BMY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional Bristol-Myers Squibb (BMY) trades public?
Yes. Every congressional trade in Bristol-Myers Squibb (BMY) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Bristol-Myers Squibb (BMY)?
Members of Congress have disclosed 332 trades in Bristol-Myers Squibb (BMY) worth $6.9M across 56 members, according to public STOCK Act filings.
Which members of Congress have traded Bristol-Myers Squibb (BMY)?
Recent and active filers of Bristol-Myers Squibb (BMY) disclosures include Rohit Khanna, Gilbert Cisneros, Julie Johnson. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Bristol-Myers Squibb (BMY) more?
Across disclosed Bristol-Myers Squibb (BMY) trades, 47% were by Democrats and 53% by Republicans, led by Republicans (53%).
What is the most recent congressional Bristol-Myers Squibb (BMY) trade?
The most recent disclosed Bristol-Myers Squibb (BMY) trade was a purchase by Alan Armstrong, filed Jul 20, 2026.
What is Bristol-Myers Squibb (BMY)'s Tide Score?
Bristol-Myers Squibb (BMY) has a Quantellect Tide Score of 72 (High Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.
Browse all stocks Congress tradesCongressional trading overviewBristol-Myers Squibb (BMY) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.